The spectrum of neuromyelitis optica

Lancet Neurology

Volumn 6, Issue 9, 2007, Pages 805-815

  Wingerchuk, Dean M ^a   Lennon, Vanda A ^b,c   Lucchinetti, Claudia F ^b   Pittock, Sean J ^b   Weinshenker, Brian G ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; AUTOANTIBODY; AZATHIOPRINE; BETA INTERFERON; CORTICOSTEROID; GLATIRAMER; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PREDNISONE;

AUTOIMMUNE DISEASE; BLADDER DYSFUNCTION; BRAIN; CEREBROSPINAL FLUID ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EYE PAIN; HUMAN; IMMUNOPRECIPITATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; PARAPLEGIA; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REVIEW; SEX RATIO; SJOEGREN SYNDROME; SPINAL CORD; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL IMPAIRMENT;

ANIMALS; AQUAPORIN 4; AUTOANTIBODIES; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, IMMUNOLOGICAL; NEUROMYELITIS OPTICA;

EID: 34547791832     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70216-8     Document Type: Review

References (120)

1. Noseworthy J., Lucchinetti C., Rodriguez M., and Weinshenker B. Multiple sclerosis. N Engl J Med 343 (2000) 938-952
2. Polman C., Reingold S., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58 (2005) 840-846
3. Frohman E., Racke M., and Raine C. Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 354 (2006) 942-955
4. Kantarci O., and Weinshenker B. Natural history of multiple sclerosis. Neurol Clin 23 (2005) 17-38
5. Wingerchuk D., Hogancamp W., O'Brien P., and Weinshenker B. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53 (1999) 1107-1114
6. Cree B., Goodin D., and Hauser S. Neuromyelitis optica. Semin Neurol 22 (2002) 105-122
7. de Seze J. Neuromyelitis optica. Arch Neurol 60 (2003) 1336-1338
8. Weinshenker B. Neuromyelitis optica: what it is and what it might be. Lancet 361 (2003) 889-890
9. Wingerchuk D., Lennon V., Pittock S., Lucchinetti C., and Weinshenker B. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
10. Lennon V., Wingerchuk D., Kryzer T., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
11. Lennon V., Kryzer T., Pittock S., Verkman A., and Hinson S. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin 4 water channel. J Exp Med 202 (2005) 473-477
12. Amiry-Moghaddam M., and Ottersen O. The molecular basis of water transport in the brain. Nat Rev Neurosci 4 (2003) 991-1001
13. Devic E. Myélite aiguë compliquée de névrite optique. Bull Med (Paris) 8 (1894) 1033-1034
14. Gault F. De la neuromyélite optique aiguë. Lyon; 1894.
15. Scolding N. Devic's disease and autoantibodies. Lancet Neurol 4 (2005) 136-137
16. O'Riordan J., Gallagher H., Thompson A., et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60 (1996) 382-387
17. Wingerchuk D., and Weinshenker B. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 60 (2003) 848-853
18. Misu T., Fujihara K., Nakashima I., Sato S., and Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 65 (2005) 1479-1482
19. Pittock S., Weinshenker B., and Wijdicks E. Mechanical ventilation and tracheostomy in multiple sclerosis. J Neurol Neurosurg Psychiatry 75 (2004) 1331-1333
20. Howard R., Wiles C., Hirsch N., Loh L., Spencer G., and Newsom-Davis J. Respiratory involvement in multiple sclerosis. Brain 115 (1992) 479-494
21. Kurtzke J. Cinical manifestations of multiple sclerosis. In: Vinken P., and Bruyn G. (Eds). Handbook of Clinical Neurology (1970), North-Holland, Amsterdam 161-216
22. de Seze J., Stojkovic T., Ferriby D., et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197 (2002) 57-61
23. Chalumeau-Lemoine L., Chretien F., Gaelle Si Larbi A., et al. Devic disease with brainstem lesions. Arch Neurol 63 (2006) 591-593
24. Pittock S., Lennon V., Krecke K., Wingerchuk D., Lucchinetti C., and Weinshenker B. Brain abnormalities in neuromyelitis optica. Arch Neurol 63 (2006) 390-396
25. Papais-Alvarenga R., Miranda-Santos C., Puccioni-Sohler M., et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 73 (2002) 429-435
26. Bot J., Barkhof F., Polman C., et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62 (2004) 226-233
27. Mandler R., Ahmed W., and Dencoff J. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51 (1998) 1219-1220
28. Milano E., Di Sapio A., Malucchi S., et al. Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse. Neurol Sci 24 (2003) 130-133
29. McDonald W., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
30. Ebers G., and Paty D. CSF electrophoresis in one thousand patients. Can J Neurol Sci 7 (1980) 275-280
31. McLean B., Luxton R., and Thompson E. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-index: a comparison and diagnostic applications. Brain 113 (1990) 1269-1289
32. Bergamaschi R., Tonietti S., Franciotta D., et al. Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler 10 (2004) 2-4
33. Mandler R., Davis L., Jeffery D., and Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34 (1993) 162-168
34. de Seze J., Lebrun C., Stojkovic T., Ferriby D., Chatel M., and Vermersch P. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 9 (2003) 521-525
35. Ghezzi A., Bergamaschi R., Martinelli V., et al. Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol 251 (2004) 47-52
36. Barbieri F., and Buscaino G. Neuromyelitis optica in the elderly. Acta Neurol 11 (1989) 247-251
37. Davis R., Thiele E., Barnes P., and Riviello Jr. J. Neuromyelitis optica in childhood: case report with sequential MRI findings. J Child Neurol 11 (1996) 164-167
38. Mirsattari S., Johnston J., McKenna R., et al. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology 56 (2001) 317-323
39. Osuntokun B. The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria. J Neurol Sci 12 (1971) 417-442
40. Cosnett J. Multiple sclerosis and neuromyelitis optica. Case report and speculation. S Afr Med J 60 (1981) 249-251
41. Modi G., Mochan A., Modi M., and Saffer D. Demyelinating disorder of the central nervous system occurring in black South Africans. J Neurol Neurosurg Psychiatry 70 (2001) 500-505
42. Phillips P., Newman N., and Lynn M. Optic neuritis in African Americans. Arch Neurol 55 (1998) 186-192
43. Cree B., Khan O., Bourdette D., et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 63 (2004) 2039-2045
44. Cabre P., Heinzlef O., Merle H., et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology 56 (2001) 507-514
45. Vernant J., Cabre P., Smadja D., et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 48 (1997) 58-64
46. Fukazawa T., Yamasaki K., Ito H., et al. Both the HLA-CPB1 and DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens 55 (2000) 199-205
47. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2 (2003) 117-127
48. Nakashima I., Fujihara K., Takase S., and Itoyama Y. Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med 188 (1999) 89-94
49. Yamasaki K., Horiuchi I., Minohara M., et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122 (1999) 1689-1696
50. Lau K., Wong L., Li L., Chan Y., Li H., and Wong V. Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey. Hong Kong Med J 8 (2002) 77-80
51. Das A., and Puvanendran K. A retrospective review of patients with clinically definite multiple sclerosis. Ann Acad Med Singapore 27 (1998) 204-209
52. Chopra J., Radhakrishnan K., Sawhney B., Pal S., and Banerjee A. Multiple sclerosis in North-West India. Acta Neurol Scand 62 (1980) 312-321
53. Gangopadhyay G., Das S., Sarda P., et al. Clinical profile of multiple sclerosis in Bengal. Neurol India 47 (1999) 18-21
54. Kira J., Yamasaki K., Horiuchi I., Ohyagi Y., Taniwaki T., and Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 166 (1999) 53-57
55. Ch'ien L., Medeiros M., Belluomini J., Lemmi H., and Whitaker J. Neuromyelitis optica (Devic's syndrome) in two sisters. Clin Electroencephalogr 13 (1982) 36-39
56. McAlpine D. Familial neuromyelitis optica: its occurrence in identical twins. Brain 61 (1938) 430-448
57. Yamakawa K., Kuroda H., Fujihara K., et al. Familial neuromyelitis optica (Devic's syndrome) with late onset in Japan. Neurology 55 (2000) 318-319
58. Wingerchuk D., Pittock S., Lucchinetti C., Lennon V., and Weinshenker B. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 68 (2007) 603-605
59. Cloys D., and Netsky M. Neuromyelitis Optica (1970), North-Holland, Amsterdam
60. Lucchinetti C., Mandler R., McGavern D., et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125 (2002) 1450-1461
61. Lefkowitz D., and Angelo J. Neuromyelitis optica with unusual vascular changes. Arch Neurol 41 (1984) 1103-1105
62. Nakamura M., Endo M., Murakami K., Konno H., Fujihara K., and Itoyama Y. An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler 11 (2005) 735-738
63. Jacobs D., Roemer S., Weinshenker B., et al. The pathology of brain involvement in neuromyelitis optica spectrum disorder. Mult Scler 12 (2006) S155
64. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47 (2000) 707-717
65. Roemer S., Parisi J., Lennon V., et al. Pattern specific loss of aquaporin 4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130 (2007) 1194-1205
66. Misu T., Fujihara K., Kakita A., et al. Loss of aquaporin 4 in lesions in neuromyelitis optica: distinction from multiple sclerosis. Brain 130 (2007) 1224-1234
67. Misu T., Kakita A., Fujihara K., et al. A comparative neuropathological analysis of Japanese cases of neuromyelitis optica and multiple sclerosis. Neurology 64 (2005) A39
68. Misu T., Fujihara K., Nakamura M., et al. Loss of aquaporin 4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 209 (2006) 269-275
69. Sinclair C., Kirk J., Herron B., Fitzgerald U., and McQuaid S. Absence of aquaporin 4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol 113 (2007) 187-194
70. Pittock S., Lennon V., Wingerchuk D., Homburger H., Lucchinetti C., and Weinshenker B. The prevalence of non-organ-specific autoantibodies and NMO-IgG in neuromyelitis optica (NMO) and related disorders. Neurology 66 (2006) A307
71. Hummers L., Krishnan C., Casciola-Rosen L., et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 62 (2004) 147-149
72. Pittock SJ, Lennon VA, De Seze J, et al. Neuromyelitis optica spectrum disorders and non-organ-specific autoimmunity. Arch Neurol (in press).
73. Nakashima I., Fujihara K., Miyazawa I., et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77 (2006) 1073-1075
74. Zuliani L., Lopez de Munain A., Ruiz Martinez J., Olascoaga J., Graus F., and Saiz A. NMO-IgG antibodies in neuromyelitis optica: a report of 2 cases. Neurologia 21 (2006) 314-317
75. Littleton E., Jacob A., Boggild M., and Palace J. An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica. Mult Scler 12 (2006) S156
76. Marignier R., De Seze J., Durand-Dubief F., et al. NMO-IgG: a French experience. Mult Scler 12 (2006) S4
77. Akman-Demir G. Probably NMO-IgG in Turkish patients with Devic's disease and multiple sclerosis. Mult Scler 12 (2006) S157
78. Jarius S., Franciotta D., Bergamaschi R., et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68 (2007) 1076-1077
79. Matsuoka T., Matsushita T., Kawano Y., et al. Heterogeneity of aquaporin 4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130 (2007) 1206-1223
80. Takahashi T., Fujihara K., Nakashima I., et al. Anti- aquaporin 4 antibody is involved in the pathogenesis of NMO: a study on antibody titer. Brain 130 (2007) 1235-1243
81. Agre P., and Kozono D. Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett 555 (2003) 72-78
82. Nielsen S., Nagelhus E., Amiry-Moghaddam M., Bourque C., Agre P., and Ottersen O. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin 4 in rat brain. J Neurosci 17 (1997) 171-180
83. Pittock S., Weinshenker B., Lucchinetti C., Wingerchuk D., Corboy J., and Lennon V. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63 (2006) 964-968
84. Poppe A., Lapierre Y., Melancon D., et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 11 (2005) 617-621
85. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 23 (2005) 683-747
86. Morgan B., and Gasque P. Expression of complement in the brain: role in health and disease. Immunol Today 17 (1996) 461-466
87. Rubiera M., Rio J., Tintore M., et al. Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis. Neurology 66 (2006) 1568-1570
88. Saiz A., Zuliani L., Blanco Y., et al., for the Spanish-Italian NMO study group. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol (2007). published online April 2. DOI: 10.1007/s00415-007-0509-8
89. Barkhof F., Filippi M., Miller D., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 (1997) 2059-2069
90. Yamasaki K., Horiuchi I., Minohara M., et al. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med 39 (2000) 296-299
91. Filippi M., Rocca M., Moiola L., et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology 53 (1999) 1705-1710
92. Rocca M., Agosta F., Mezzapesa D., et al. Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 62 (2004) 476-478
93. Yu C., Lin F., Li K., et al. Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica. AJNR Am J Neuroradiol 27 (2006) 1009-1015
94. Chan K., Tsang K., Fong G., Cheung R., and Ho S. Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica. Clin Neurol Neurosurg 107 (2005) 132-135
95. Katz J., and Ropper A. Progressive necrotic myelopathy: clinical course in 9 patients. Arch Neurol 57 (2000) 355-361
96. Kidd D., Burton B., Plant G., and Graham E. Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126 (2003) 276-284
97. Pirko I., Blauwet L., Lesnick T., and Weinshenker B. The natural history of recurrent optic neuritis. Arch Neurol 61 (2004) 1401-1405
98. Okai A., Muppidi S., Bagla R., and Leist T. Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?. Neurol Res 28 (2006) 354-359
99. Weinshenker B., Wingerchuk D., Vukusic S., et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59 (2006) 566-569
100. Chan A., and Liu D. Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome. Rheumatology 45 (2006) 120-121
101. Lehnhardt F., Impekoven P., Rubbert A., et al. Recurrent longitudinal myelitis as primary manifestation of SLE. Neurology 63 (2004) 1976
102. Krishnan A., and Halmagyi G. Acute transverse myelitis in SLE. Neurology 62 (2004) 2087
103. Giorgi D., Balacco Gabrieli C., and Bonomo L. The association of optic neuropathy with transverse myelitis in systemic lupus erythematosus. Rheumatology 38 (1999) 191-192
104. Mochizuki A., Hayashi A., Hisahara S., and Shoji S. Steroid-responsive Devic's variant in Sjogren's syndrome. Neurology 54 (2000) 1391-1392
105. Yamamoto T., Ito S., and Hattori T. Acute longitudinal myelitis as the initial manifestation of Sjogren's syndrome. J Neurol Neurosurg Psychiatry 77 (2006) 780
106. Tan E., Cohen A., Fries J., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
107. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 (2002) 554-558
108. Misu T., Fujihara K., Nakashima I., et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain 125 (2002) 2460-2468
109. Weinshenker B., Wingerchuk D., Nakashima I., Fujihara K., and Lennon V. OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5 (2006) 110-111
110. Weinshenker B., O'Brien P., Petterson T., et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46 (1999) 878-886
111. Watanabe S., Nakashima I., Misu T., et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 13 (2007) 128-132
112. Keegan M., Pineda A., McClelland R., Darby C., Rodriguez M., and Weinshenker B. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58 (2002) 143-146
113. Ruprecht K., Klinker E., Dintelmann T., Rieckmann P., and Gold R. Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 63 (2004) 1081-1083
114. Wingerchuk D., and Weinshenker B. Neuromyelitis optica. Curr Treat Options Neurol 7 (2005) 173-182
115. Papeix C., Vidal J., de Seze J., et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13 (2007) 256-259
116. Warabi Y., Matsumoto Y., and Hayashi H. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 252 (2007) 257-261
117. Weinstock-Guttman B., Ramanathan M., Lincoff N., et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 63 (2006) 957-963
118. Bakker J., and Metz L. Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG). Can J Neurol Sci 31 (2004) 265-267
119. Cree B., Lamb S., Morgan K., Chen A., Waubant E., and Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64 (2005) 1270-1272
120. Kerr D. The lumping and splitting of inflammatory CNS diseases. Neurology 66 (2006) 1466-1467